VCEL — Vericel Corp

—
Nasdaq · Health Care · Biotechnology · CIK 887359 ·
Last close
$57.88
Market Cap
$2.95B
52W High
$59.75
52W Low
$28.95
ADV30
809,970
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 85,371,000 62,610,000 12,186,000 14,161,000 517,110,000 133,493,000 132,938,000
Jun 2026 77,457,000 56,402,000 434,000 2,206,000 502,866,000 125,358,000 132,825,000
Mar 2026 68,425,000 49,266,000 -8,064,000 -6,302,000 485,627,000 109,295,000 129,396,000
Dec 2025 92,918,000 73,128,000 22,415,000 23,243,000 487,969,000 100,092,000 133,329,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$69,670,000
Investing CF
$-26,788,000
Financing CF
$1,944,000
CapEx
$-8,006,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.47
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-380,393,000
Inventory
$18,382,000
Receivables
$75,712,000
ST Investments
$37,100,000
EBIT TTM
$25,720,000
Pretax Income TTM
$25,080,000
Interest Exp TTM
$640,000
Analysts
7

Yahoo Snapshot (yfinance, live)

Total Revenue
$324,171,008
EBITDA
$40,573,000
Free Cash Flow
$49,890,624
Enterprise Value
$2,708,124,928
Total Cash
$170,268,000
Total Debt
$91,147,000
Shares Out
51,029,770
Trailing EPS
$0.64
Book Value
$7.53
ROE
9.4%
ROA
3.5%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 276,259,000 11,044,000 16,518,000 487,969,000 133,329,000 354,640,000 51,910,000
Dec 2024 237,224,000 4,519,000 10,362,000 432,722,000 140,755,000 291,967,000 58,163,000
Dec 2023 197,516,000 -6,464,000 -3,182,000 353,657,000 127,705,000 225,952,000 35,311,000
Dec 2022 164,365,000 -17,058,000 -16,709,000 273,003,000 80,731,000 192,272,000 17,687,000

TTM Snapshot

Revenues TTM
$306,303,000
NetIncome TTM
$24,221,000
OpCashFlow TTM
—
Assets (Latest)
$502,866,000
Forward EPS
$0.85

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $35.00 · spot: $58.65 · call volume: 80 · put volume: 6
Expected Move to 2027-01-15: ±$8.10 (13.81%) — implied range $50.55 – $66.75 · ATM straddle on $60.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
DNLI Denali Therapeutics Inc. $2.89B $18.00 —
ADMA ADMA BIOLOGICS, INC. $3.02B $13.63 —
IOVA IOVANCE BIOTHERAPEUTICS, INC. $3.48B $7.53 —
RLAY Relay Therapeutics, Inc. $3.64B $16.47 —
TARS Tarsus Pharmaceuticals, Inc. $3.86B $78.20 —

News headlines (Yahoo Finance, 1h cache)

Vericel to Present at the Stephens Annual Investment Conference on Wednesday, November 18, 2026
2026-11-13 13:30 · Yahoo
Earnings Estimates Moving Higher for Vericel (VCEL): Time to Buy?
2026-11-10 19:40 · Yahoo
Vericel (VCEL) Jumped, What Is Behind The Move?
2026-11-07 00:18 · Yahoo
Vericel Q3 Earnings Call Highlights
2026-11-06 20:14 · Yahoo
Vericel Corp (VCEL) (Q3 2026) Earnings Call Highlights: Record Revenue and Tripled Net Income ...
2026-11-05 23:19 · Yahoo
Vericel Corp (VCEL) Q3 2026 Earnings Call Transcript
2026-11-05 19:49 · Yahoo
Vericel (VCEL) Stock Looks Overvalued Given Its Earnings Support
2026-11-05 14:11 · Yahoo
Vericel Corporation (VCEL) Beats Q3 Earnings and Revenue Estimates
2026-11-05 13:35 · Yahoo
Vericel Reports Third Quarter 2026 Financial Results and Raises Full-Year Financial Guidance
2026-11-05 12:55 · Yahoo
Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026
2026-10-22 12:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.